Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
Description
A 12 month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.
Study Start Date
March, 30 2018
Estimated Completion Date
December 2019
Interventions
- Drug: Abaloparatide
- Drug: Placebo
Study ID
Radius Health, Inc. -- BA058-05-019
Status
Unknown
Trial ID
Study Type
Interventional
Trial Phase
Phase 3
Enrollment Quota
225
Sponsor
Radius Health, Inc.
Gender
Male
Ages
40 Years to 85 Years
Accepts Healthy Volunteers
No
Study Locations and Contact Information (1)
Study Location | Distance | Name | Phone | |
---|---|---|---|---|
Radius Health Inc - Waltham, Massachusetts | 132.4 miles | Study Director | None | None |